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A study was conducted in healthy elderly living independently in senior housing to assess the impact of a probiotic yoghurt supplement on small
intestinal bacterial overgrowth. Twenty-three participants with positive and thirteen participants with negative hydrogen breath test were studied
before and after a period of 4 weeks of probiotic yoghurt administration. Intestinal permeability, plasma endotoxin levels, phagocytic activity of
leucocytes, cytokine production by monocytes and free radical response of neutrophils were determined. Intestinal permeability was similar for the
two groups and was unaffected by probiotic treatment. Both plasma endotoxin levels and the basal phagocytic activity of leucocytes decreased
after yoghurt intake in the two groups. Exposure of monocytes and neutrophils ex vivo led to an increased cytokine response and free radical
response, respectively. The normalisation of the various cytokine responses was more apparent in the group with positive breath test. In addition,
the plasma levels of lipoplysaccharide binding protein and soluble CD14, lipoplysaccharide pattern recognition receptors and surrogate markers of
lipoplysaccharide permeability were diminished by the end of the study. In conclusion, probiotic administration in the elderly normalises the
response to endotoxin, and modulates activation markers in blood phagocytes, and therefore may help reduce low-grade chronic inflammation.
Probiotics: Immunity: Elderly: Small-intestinal bacterial overgrowth
Small-intestinal bacterial overgrowth (SIBO) should always
be suspected in elderly subjects that suffer from chronic diar-
rhoea, anorexia or nausea(1). It has been defined quantitatively
as more than 105 colony-forming units/ml of bacteria in the
fluid of the proximal small bowel and can be associated
with malabsorption and malnutrition in the elderly(2).
The relatively high prevalence of SIBO in the elderly
may result from hypochlorhydria caused by atrophic gastritis
or by antacid treatments(3). However, mucosal dysmotility,
frequently associated with type 2 diabetes, and alterations
of the mucosal immune system(4) can also be contributing
factors. Besides causing impairment of digestive and absorp-
tive function SIBO is also frequently associated with increased
intestinal permeability(5). The passage of bacterial products
into the intestinal mucosa and the portal vein may play an
important role in the altered intestinal digestive/absorptive
function, the metabolism, and the low-grade inflammation in
the elderly. Administration of probiotic-containing yoghurt
may improve the clinical condition by improving gut barrier
function and and by its antibacterial, immunomodulatory
and/or anti-inflammatory effects(6).
The current study examined the effects of an orally adminis-
tered probiotic-containing yoghurt in an elderly population
with a positive glucose/H2 breath test, and as such a suspected
SIBO, compared to those with a negative glucose/H2 breath
test. More specifically, effects on intestinal colonisation, gut
permeability, endotoxin translocation and modification of
innate immune functions were assessed.
Methods
Population/study design and product administration
Elderly subjects of both sexes (aged 61–94, mean 76·9 (SD 7·3)
years) were recruited from a random sample of 294 elderly
subjects that participated in a cross-sectional survey study
conducted to determine the prevalence of SIBO based on
the excretion in exhaled breath of hydrogen generated by
the metabolism of glucose by intestinal bacteria(7,8). Volun-
teers were not included if they were suffering from viral or
bacterial infections, had been under antibiotics in the pre-
ceding 3 weeks, or suffered from any acute or chronic disease
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including malignancies, or had been subjected to any form of
gastro-intestinal surgery. The prevalence of SIBO found with
the H2 breath test was 15 %
(8).
Twenty-three elderly subjects (eighteen women, five men)
with positive breath test (SPH) and thirteen subjects (nine
women, four men) with negative breath test (SNH) were
included in a follow-up, where the yogurt was administrated
(observational study with one treatment group).
Subjects repeated the breath test at the beginning of
the study and were asked to consume probiotic yogurt
(2 £ 150 g) Lactobacillus johnsonii La1 (daily dose of 109
colony-forming units) for 4 weeks with a previous restriction
of 2 weeks for yoghurt, kefir or butter milk. During the 4-week
consumption of the study subjects were not allowed to
consume other fermented products. No other advice with
regard to diet was given to the participants. They were allowed
to continue routine treatment and medication for stable
conditions.
Hygrogen breath test
Hydrogen concentration (parts per million; ppm) in exhaled
air was determined after ingestion of 50 g glucose as described
by Parlesak et al. (8). A positive result of the H2 test was taken
as a rise of at least 10 ppm of expired H2 over baseline within
75 min. The breath test was performed at the baseline (pre-
valence study(8)), before probiotic administration (1 week
later) and after the 4 weeks of probiotic yoghurt consumption.
Intestinal permeability assessment was performed with
polyethylene glycol of different molecular weights (400,
1500, 4000, 10 000) as previously described(9).
Endotoxin determination was carried out before and after
probiotic yoghurt consumption in peripheral venous blood as
previously described(10,11).
Ex vivo phagocytic activity and cytokine production after
stimulation with lipopolysaccharide (LPS) (Escherichia coli
0111:B4) was performed on peripheral blood mononuclear cells.
Phagocytosis in human whole blood was performed using
opsonised, fluorescein isothiocyanate-labelled E. coli (PHAGO-
TESTe; Becton Dickinson, Basel, Switzerland) and flow
cytometry as described previously(12).
For the determination of cytokine release by monocytes per-
ipheral blood mononuclear cells were separated from whole
blood by gradient centrifugation with Ficollq.
Cytokine production by monocytes was determined as
follows: monocytes were purified by adhesion to plastic
dishes during 1·5 h. Cells were thereafter stimulated by the
addition of 10 ng/ml endotoxin from E. coli 0111:B4
(Sigma, Stuttgart, Germany). Cell culture supernatants were
collected at 2·5 h for the determination of TNF-a and IL-1b
and at 20 h for the determination of IL-10. Cytokine concen-
trations were measured with commercially available ELISA
kits (Pharmingen, Heidelberg, Germany).
Release of reactive oxygen species by neutrophils proce-
dure and evaluation are described in detail in a previous
publication(13). Neutrophils were isolated from whole blood
by gradient centrifugation with Polymorphprep (Nycomed,
Oslo, Norway). The chemiluminescence emitted by the
LPS-stimulated neutrophils from SPH and SNH groups was
assessed as the area under the curve in an assay that covers
1 h post-stimulation with different LPS concentrations.
Statistical analysis
The study presented has to be considered as an exploratory
clinical trial. The design consists of one treatment group.
The effect of the yogurt was investigated by a pre-post com-
parison. The observed differences may be due to treatment,
but also due to ‘regression to the mean’ as well as due to
unknown confounders. Measurements of H2 breath test are
not approximately normally distributed. Also log transform-
ation did not achieve the desired distributional characteristics.
Consequently summary statistics are presented by median and
quartiles and inferential statistics is performed by Wilcoxon
sign-rank test. Treatment differences and CI are estimated
according to Hodges & Lehmann(14).
The other outcomes are approximately normally or log-
normally distributed. Summary statistics are presented by
means and their standard errors. Inferential statistics was per-
formed by the t test. We are aware that our exploratory
research may produce also false positive results. Therefore
the P values presented throughout this report are interpreted
as flags in order to indicate an interesting result. This interpreta-
tion is also in agreement with the international conference of
harmonisation guideline, ICH E9.
Results
From the 294 subjects, only 279 subjects were further investi-
gated in the cross-sectional screening study (data not shown).
In this sample, thirty-eight elderly showed a positive hydrogen
breath test (SPH) and 241 showed a negative hydrogen breath
test (SNH). The cut point was 10 ppm. SPH elderly, showing
compliance, were invited to participate in next stage of the
study, resulting in twenty-three SPH participants (eighteen
women, five men). Additionally thirteen SNH elderly were
enrolled in the study (nine women, four men). The mean age
was 78·6 (SD 7·8) and 77·5 (SD 5·8) years for the SPH and
SNH subjects, respectively. Both groups were comparable in
anthropometric data (weight 66 (SD 15) and 71 (SD 12) kg;
BMI 24·0 (SD 3·8) and 25·8 (SD 3·6) kg/m2, for SPH and
SNH elderly, respectively).
The H2 breath test was performed three times in each sub-
ject, on screening, before and on the last day of yogurt con-
sumption, 4 weeks later.
Development over time of the H2 hydrogen breath test
for each observation group (SPH, SNH) is presented in
Fig. 1. The SPH subjects are showing a significant decrease
(218 ppm; 95 % CI 234·5, 27·5; P¼0·006) from screening
until start of yogurt intake and then are remaining relatively
stable until end of yogurt intake (þ1·0 ppm; 95 % CI 213·5,
12·0; P¼0·87). SNH subjects were consistently negative
(,10 ppm) in all three determinations and do not show rele-
vant changes from screening until start (20·5 ppm; 95 % CI
23·0, 2·5; P¼0·75) and until end of yogurt intake
(^0·0 ppm; 95 % CI 22·5, 2·0; P¼0·80).
Intestinal permeability
No significant association of increased intestinal permeability to
macromolecules (polyethylene glycol) with small bowel intesti-
nal overgrowth was observed, and no change was observed
as a result of the probiotic yogurt intake (data not shown).
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Endotoxin concentration
Before treatment no differences were observed for endotoxin
concentrations in peripheral venous blood between subjects
of the different groups (6·49 (SEM 8·1) for SPH v. 6·4 (SEM
6·3) pg/ml for the SNH group; Fig. 2). After the 4 weeks of
probiotic yogurt consumption a trend towards a diminution
of endotoxin concentration was observed in the SPH group
(6·49 (SEM 8·1) v. 4·6 (SEM 5·6) pg/ml). While in the SNH
group plasma endotoxin was significantly lower after probiotic
yoghurt consumption (6·4 (SEM 6·3) v. 0·5 (SEM 0·0) pg/ml,
P¼0·043, before v. after).
Haematological parameters
Complete blood cell count, erythrocyte sedimentation, total
plasma protein, albumin, C-reactive protein and parameters
associated to liver, renal and immune functions were analysed
before and after the probiotic yogurt consumption. The groups
were not different at the start of the ingestion period and no
clinically significant changes were observed at the end (data
not shown).
Soluble CD14 (sCD14) plays a pivotal role in LPS recog-
nition of LPS-induced cell activation. LPS binding protein
(LBP) is a class 1 acute-phase protein with the ability to
bind and transfer bacterial LPS to CD14 receptor(15). sCD14
and LBP were studied only in the SPH group, due to the
more restricted size of the SNH group. Plasma levels of
soluble sCD14 and LBP showed a significant decrease after
the yogurt intake period (3·806 (SEM 0·706) v. 3·580 (SEM
0·615) mg/ml for sCD14, P¼0·04) and (31 (SEM 23) v. 24
(SEM 20) mg/ml for LBP, P¼0·03).
Phacocytic activity of monocytes and neutrophils
No differences in the percentage of phagocytes were observed
between groups at the beginning of the study and there was no
significant change after the 4 weeks of intervention. The mean
fluorescence intensity is proportional to the number of incor-
porated bacteria by individual phagocytes. Mean fluorescence
intensity decreased after the consumption of probiotic yogurt
in both groups for monocytes and neutrophils (monocytes,
P¼0·011 and neutrophils, P¼0·0001 in SPH group; mono-
cytes, P¼0·036 and neutrophils, P¼0·036 in SNH group).
Cytokine release
Before yogurt consumption, monocytes isolated from subjects
of the SPH group produced significantly less IL-1b and IL-10
than subjects in the SNH group (199 (SEM 359) v. 586 (SEM
566) pg/ml, P¼0·035 for IL-1b and 759 (SEM 739) v. 1846
(SEM 1309) pg/ml, P¼0·009 for IL-10). After 4 weeks of
yoghurt consumption monocytes from SPH participants
showed an increased capacity to react to endotoxin challenge
attaining similar levels to the SNH group.
Release of reactive oxygen species
A trend towards a more elevated release of reactive oxygen
species by neutrophils was observed after the yogurt consump-
tion in both groups. The differences were statistically signifi-
cant at the highest LPS concentration in the SPH group
(P¼0·031; see Fig. 3). Reactive oxygen species production
by neutrophils from the SNH group (data not shown)
showed a similar pattern, higher after probiotic yoghurt con-
sumption, but in this case did not reach statistical significance.
Discussion
All participants had a good nutritional status and no apparent
clinical manifestation of SIBO. Of the SPH subjects enrolled in
the present study 43 % did not reach the threshold increment
of 10 ppm of H2 in the second breath test before the start of
probiotic yoghurt consumption. On the other hand, none of
Fig. 2. Endotoxin concentrations in plasma of subjects with positive breath
test (SPH, A) and subjects with negative breath tests (SNH, o) before and at
the end of the yoghurt consumption period. Values are means with their stan-
dard errors depicted by vertical bars. Mean value was significantly different
from that before the yoghurt consumption period: *P¼0·043.
Fig. 1. Boxplots of hydrogen breath test grouped by negative (2 ) and posi-
tive (þ) tests at baseline. Base, baseline; Pre, before probiotic intake (1 week
after baseline); Post, after 4-week probiotic intake.†, Median value; W, out-
liers; box, interquartile range; whiskers, last outlier not further away than 1·6
times interquartile range (corresponding to 95% CI for the median); ppm,
parts per million; . . ., the 10 ppm theshold for a normal breath test.
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the thirteen SNH subjects had a positive H2 breath test in
the second or third breath tests. The spontaneous normali-
sation of a positive H2 breath test in the SPH group may be
due to various factors.
According to most authors, the sensitivity of glucose/
H2 breath test is approximately 70 % and the specificity is
about 80 %. Thus the apparent discrepancy between the first
and the second breath tests performed 1 week apart cannot
be attributed to inherent limitations of the test alone(16).
The lack of reproducibility in the test may be due to physio-
logical or pathophysiological variations such as carbohydrate
malabsorption, gastrointestinal motor disorders with transit
abnormalities(17). The stability of the intestinal bacterial popu-
lation varies in both the number and type of colonising bac-
teria. The washout effect of diarrhoeal episodes, the loss of
bacterial flora due to antibiotic use, and acidity of the bowel
lumen may all contribute to such fluctuations(6). Although
the study participants were not treated with antibiotics, we
cannot discount transient diarrhoeal episodes, changes in
bowel motility and evacuation, or other factors which may
have contributed to the spontaneous reduction in bacterial
overgrowth observed in ten of the twenty-three SPH subjects.
Interestingly, seven of these SPH participants are once again
positive in the third test after the intervention. None of
the SNH subjects had a positive response in either the
second or third test. This highly significant difference (7/10
v. 0/13, P¼0·0003) supports the grouping of the participants
on the basis of SIBO. At the end of yoghurt consumption no
changes in the glucose/H2 breath test were observed for
either of the groups.
SIBO can increase intestinal permeability assessed by the
lactulose/mannitol test(5). Subjects with overgrowth of colonic-
like bacteria appear to have more compromised barrier
integrity and higher inflammatory response than subjects colo-
nised by other types of microbiota(5). In the present study,
the SPH and SNH subjects did not differ in their intestinal
permeability to polyethylene glycol of different molecular
weights. The consumption of probiotic yoghurt for 4 weeks
did not influence this permeability.
SIBO can be associated with an increased immune-inflam-
matory activity of the mucosal immune-competent cells.
Increased production of IL-6, higher numbers of intra-epithelial
lymphocytes and of IgA-producing cells have been associa-
ted with the intestinal bacterial load(18). The inflammatory/
immune reaction seems to be mediated by a coliform pre-
dominant microbiota.
In addition to the local effect of SIBO in the mucosal
immune compartment, leakage or translocation of bacteria
or their components into the body can contribute to visceral
toxicity, systemic inflammatory conditions and metabolic
changes. SIBO and passage of LPS into the portal vein can
be deleterious to the liver and contribute to non-alcoholic
liver disease(19,20).
It has been postulated that the subclinical inflammatory
status observed in a subgroup of elderly may be propagated
from components in the intestinal environment as a conse-
quence of a poor mucosal barrier and inadequate mucosal
clearance of the abnormally high bacterial challenge(21).
There is no strong evidence supporting an association
between translocation bacteria or their products and increased
intestinal permeability(22). Therefore, the unaltered per-
meability to polyethylene glycol does not rule out a closer
interaction of the mucosal immune cells with the abnormally
high bacterial load of the small bowel and a concomitant
increase in lamina propria cellularity(23), due to macrophage
and lymphocyte infiltration. Increased local IL-6 production
is related to the activation of lamina propria mononuclear
cells exposed to higher LPS levels. Local mucosal changes
may not be detected systemically.
Positive glucose/H2 breath test was not assocaited with
higher levels of plasma LPS as both groups had similar con-
centrations at baseline. After the consumption of the probiotic
yoghurt a significant decrease in plasma endotoxin was
observed in the SNH group and a similar trend was present
in the SPH group (Fig. 2). Since probiotic ingestion did not
alter breath test results or permeability to polyethylene
glycol, one can assume that the observed cellular changes
are due to other mechanisms besides a change in the bacterial
load of the small bowel or a compromise of mucosal barrier
integrity. An altered small bowel microbiota with lower quan-
tities of coliform endotoxin-producing bacteria may have
resulted from probiotic administration. Alternatively probiotic
administration may activate the innate macrophage system(12)
in the mucosal compartment and thereby improve LPS clear-
ance. Certainly, removal and clearance of LPS from the
body is another of the many functions associated with the
intestinal cellular compartment(24). In experimental conditions
lamina propria macrophages and intestinal epithelial cells take
up and clear LPS(24). These cells are probably also involved in
the clearance of luminally derived endotoxin and translocating
bacteria. Long-term exposure to endotoxin may render phago-
cytes tolerant to LPS and incapable of mounting an energetic
response to further challenge with bacterial products and
endotoxin in particular. It is feasible that innate immune
cells have a permanently low level of activation but paradoxi-
cally, lose their capacity to mount an effective response when
needed. This can be clearly observed in the extreme case of
Fig. 3. Release of reactive oxygen species (ROS) by neutrophils isolated
from subjects with positive breath test before (A) and at the end (r) of the
yoghurt consumption period. (P¼0·0311 for endotoxin highest dose, NS for
the rest of concentrations). Values are means with their standard errors
depicted by vertical bars.
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liver cirrhosis(25). In the present study the decreased ex vivo
phagocytic capacity of unstimulated individual cells after pro-
biotic intake suggests a decrease in basal low-grade cellular
activation in the elderly. In contrast, monocytes stimulated
ex vivo with endotoxin had a low response of cytokine pro-
duction that was increased after the consumption of probiotic
yoghurt. This change was significant in the SPH group.
The release of reactive oxygen species by neutrophils
exposed to endotoxin was similar before and after probiotic
intake, but a higher reactivity to increasing concentrations of
endotoxin was observed after probiotic administration.
Although we have no direct proof of endotoxin leakage at
the gut level there is some evidence to suggest that LBP,
sCD14 and possibly other LPS pattern recognition receptors
are important parameters for monitoring the host acute-phase
reaction secondary to bacterial product leakage into the
internal milieu. After the probiotic yoghurt administration a
significant decrease in sCD14 and LBP plasma levels was
observed.
In conclusion, monocytes and neutrophils exhibited a higher
phagocytic capacity before probiotic consumption if no chal-
lenge with LPS was performed ex vivo. In contrast, probiotic
administration normalised responsiveness to LPS ex vivo and
resulted in an increased production of cytokines and free
radicals.
A unifying explanation is that probiotic administration
probably results in a lower exposure to endotoxin in the muco-
sal microenvironment and in the body. This lower exposure
may be due to a qualitative switch from a Gram-negative
endotoxin-producing microbiota to a Gram-positive (less
pro-inflammatory) type of microbiota in the proximal small
bowel(21), and/or an activation of the innate immune system
by probiotics that results in better clearance of endotoxin
and improved immunocompetence.
Probiotics have been extensively studied for their health-
promoting activities in a variety of human conditions where
altered bacterial ecology seems to play a pathogenetic role.
The distal small bowel and the colon are where most intestinal
bacteria find their ecological niches and where probiotics may
also find a more favourable environment. Here we explored
the possibility that probiotics exert effects on abnormal bac-
terial communities along the entire length of the small
bowel. The probiotic effect we observed may be mediated
by different mechanisms: (1) competitive exclusion of colonis-
ing bacteria that are vying for the same ecological niches with
subsequent qualitative changes in the composition of the
microbiota; (2) stimulation of immune function and improve-
ment of immune competence for controlling the levels of the
bacterial populations; (3) increase in innate immune function
and endotoxin clearance; and/or (4) the induction by probio-
tics of a homeostatic mucosal immune response that can com-
pensate for the pro-inflammatory activity of the colonic-like
bacteria. Any one of the aforementioned effects alone or in
combination could be of benefit in subjects with SIBO.
The present clinical study suggests that the administration
of supplements in the elderly may benefit from the addition
of ingredients that improve the composition of the intestinal
microbiota. Moreover, the present results indicate that an
altered intestinal ecology underlies the low-grade inflamma-
tory status that favours catabolism and loss of lean body
mass in the elderly.
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